MPI1B_XENLA
ID MPI1B_XENLA Reviewed; 550 AA.
AC P30309;
DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT 01-APR-1993, sequence version 1.
DT 03-AUG-2022, entry version 106.
DE RecName: Full=M-phase inducer phosphatase 1-B;
DE EC=3.1.3.48;
GN Name=cdc25-1-b; Synonyms=cdc25b;
OS Xenopus laevis (African clawed frog).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX NCBI_TaxID=8355;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC TISSUE=Oocyte;
RX PubMed=1623517; DOI=10.1016/0092-8674(92)90540-s;
RA Kumagai A., Dunphy W.G.;
RT "Regulation of the cdc25 protein during the cell cycle in Xenopus
RT extracts.";
RL Cell 70:139-151(1992).
RN [2]
RP NUCLEOTIDE SEQUENCE [MRNA].
RX PubMed=1392080; DOI=10.1091/mbc.3.8.927;
RA Izumi T., Walker D.H., Maller J.L.;
RT "Periodic changes in phosphorylation of the Xenopus cdc25 phosphatase
RT regulate its activity.";
RL Mol. Biol. Cell 3:927-939(1992).
CC -!- FUNCTION: This protein functions as a dosage-dependent inducer in
CC mitotic control. It is a tyrosine protein phosphatase required for
CC progression of the cell cycle. It may directly dephosphorylate
CC p34(cdc2) and activate the p34(cdc2) kinase activity.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC ChEBI:CHEBI:82620; EC=3.1.3.48;
CC -!- INTERACTION:
CC P30309; P18654: Rps6ka3; Xeno; NbExp=3; IntAct=EBI-15888737, EBI-397744;
CC -!- SIMILARITY: Belongs to the MPI phosphatase family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; M94262; AAA49671.1; -; mRNA.
DR EMBL; M96858; AAA49674.1; -; mRNA.
DR PIR; A42679; A42679.
DR RefSeq; NP_001081918.1; NM_001088449.1.
DR RefSeq; XP_018106285.1; XM_018250796.1.
DR AlphaFoldDB; P30309; -.
DR SMR; P30309; -.
DR BioGRID; 99454; 1.
DR DIP; DIP-176N; -.
DR IntAct; P30309; 1.
DR iPTMnet; P30309; -.
DR PRIDE; P30309; -.
DR GeneID; 398119; -.
DR KEGG; xla:398119; -.
DR CTD; 398119; -.
DR Xenbase; XB-GENE-944825; cdc25c.L.
DR OMA; FRTNCRM; -.
DR OrthoDB; 1423329at2759; -.
DR Proteomes; UP000186698; Chromosome 3L.
DR GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC.
DR GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR GO; GO:1902751; P:positive regulation of cell cycle G2/M phase transition; IEA:InterPro.
DR GO; GO:0006470; P:protein dephosphorylation; IEA:InterPro.
DR CDD; cd01530; Cdc25; 1.
DR Gene3D; 3.40.250.10; -; 1.
DR InterPro; IPR000751; MPI_Phosphatase.
DR InterPro; IPR001763; Rhodanese-like_dom.
DR InterPro; IPR036873; Rhodanese-like_dom_sf.
DR Pfam; PF06617; M-inducer_phosp; 1.
DR Pfam; PF00581; Rhodanese; 1.
DR PRINTS; PR00716; MPIPHPHTASE.
DR SMART; SM00450; RHOD; 1.
DR SUPFAM; SSF52821; SSF52821; 1.
DR PROSITE; PS50206; RHODANESE_3; 1.
PE 1: Evidence at protein level;
KW Cell cycle; Cell division; Hydrolase; Mitosis; Protein phosphatase;
KW Reference proteome.
FT CHAIN 1..550
FT /note="M-phase inducer phosphatase 1-B"
FT /id="PRO_0000198652"
FT DOMAIN 401..508
FT /note="Rhodanese"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00173"
FT REGION 76..98
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 285..335
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 286..314
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 315..335
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT ACT_SITE 457
FT /evidence="ECO:0000250"
SQ SEQUENCE 550 AA; 62183 MW; FCEC83AB66FCC5B0 CRC64;
MAESHIMSSE APPKTNTGLN FRTNCRMVLN LLREKDCSVT FSPEQPLTPV TDLAVGFSNL
STFSGETPKR CLDLSNLGDE TAPLPTESPD RISSGKVESP KAQFVQFDGL FTPDLGWKAK
KCPRGNMNSV LPRLLCSTPS FKKTSGGQRS VSNKENEGEL FKSPNCKPVA LLLPQEVVDS
QFSPTPENKV DISLDEDCEM NILGSPISAD PPCLDGAHDD IKMQNLDGFA DFFSVDEEEM
ENPPGAVGNL SSSMAILLSG PLLNQDIEVS NVNNISLNRS RLYRSPSMPE KLDRPMLKRP
VRPLDSETPV RVKRRRSTSS SLQPQEENFQ PQRRGTSLKK TLSLCDVDIS TVLDEDCGHR
QLIGDFTKVY ALPTVTGRHQ DLRYITGETL AALIHGDFSS LVEKIFIIDC RYPYEYDGGH
IKGALNLHRQ EEVTDYFLKQ PLTPTMAQKR LIIIFHCEFS SERGPKMCRF LREEDRARNE
YPSLYYPELY LLKGGYKDFF PEYKELCEPQ SYCPMHHQDF REELLKFRTK CKTSVGDRKR
REQIARIMKL